Tuesday, March 9th
Abstract: This presentation
provides an overview of how the coming wave of Virtual Reality and Augmented
Reality, Machine Learning and Biosensing Technology are converging and
elaborates how this convergence will impact clinical care, disability
solutions, and personal health and wellness.
Although entertainment, social
connection, and gaming is driving the initial adoption of VR and AR technology,
the deepest and most significant impact of the next generation of VR/AR
technology will be to enhance clinical care and to improve personal health and
wellness. VR and AR technology will also help facilitate the shift of medicine
from clinic-based care to telemedicine based care, and to facilitate
We know from decades of clinical
research that VR/AR technology can provide breakthrough solutions that address
the most difficult problems in healthcare - ranging from mood disorders such as
Anxiety and Depression to PTSD, Addictions, Autism, Cognitive Aging, Stroke
Recovery, and Physical Rehabilitation, to name just a few.
VR and AR Systems can be used to
improve medical training such as surgical skill training and procedure planning
by applying simulation-based learning principals. Personal health and wellness
will be improved by using VR to promote healthy lifestyles and to reduce stress
VR/AR technology, when combined with
Machine Learning and Biosensing technology can be used to improve clinical
measurements and assessments by making them more objective and functional. As
the cost of healthcare rises, this confluence of emerging technology well be
used as the foundation for next-generation telemedicine platforms to reduce
costs of care delivery, improve clinical efficiency, and reach previously
Greenleaf is a neuroscientist and a medical technology developer working at
Stanford University. With over three decades of research and development
experience, Walter is considered a leading authority in the field of digital
medicine and medical virtual reality technology.
Focus: Walters current research focus is on developing computer
supported clinical products, with a specific emphasis on applying virtual
reality and digital health technology to address difficult problems in
behavioral and physical medicine such as Post-traumatic Stress, Anxiety
Disorders, Depression, Traumatic Brain Injury and Stroke, Addictions, and
Autism Spectrum Disorder.
research was on age-related changes in the neuroendocrine system and the
effects on human behavior.
Positions: Walter is currently a Distinguished Visiting Scholar at
Stanford Universitys MediaX Program, a Visiting Scholar at
Stanford Universitys Virtual Human Interaction Lab, and the Director
of Technology Strategy at the University of Colorado National Mental Health
Innovation Center. He previously served as the Director of the Mind
Division, Stanford Center on Longevity, where his focus was on age-related
changes in cognition.
Product Development: Walter has designed and developed numerous clinical
systems over the last thirty-five years, including products in the fields of:
surgical simulation, 3D medical visualization, telerehabilitation, clinical
informatics, clinical decision support, point-of-care clinical data collection,
ergonomic evaluation technology, automatic sleep-staging systems,
psychophysiological assessment, and simulation-assisted rehabilitation
technologies, as well as digital eHealth products for behavioral
Leadership: Walter is the Co-founder and Board Chair for the
International Virtual Reality Health Association (IVRHA).
establish the California State University Center for Disability Solutions
and the International Society of Virtual Rehabilitation (ISVR).
as the Co-Organizer for three yearly conferences: The VR and Behavioral
Healthcare Symposium, the Annual Virtual Reality and Healthcare
Symposium, and the European Virtual Reality and Healthcare
Walter is a
scientific advisor and grant reviewer for the U.S. Public Health Service,
National Science Foundation (NSF), National Institutes of Health (NIH), Canada
Fondation for Innovation (CFI), NASA, and the U.S. Department of Education
(DoED). He has served as the Principal Investigator for research projects
funded by the NIH and by NASA.
Management: Walter founded and served as CEO for Greenleaf Medical
Systems, a medical product development company; InWorld Solutions, a
company specializing in the therapeutic use of virtual worlds for behavioral
health care; and Virtually Better, a company that develops virtual
environments for the treatment of phobias, anxiety disorders, and PTSD. Walter
served as the founding Chief Science Officer for Pear Therapeutics and
as the SVP of Strategic & Corporate Affairs to MindMaze.
Journals: Walter is an Associate Editor for three academic journals:
JMIR Mental Health, the Journal of Virtual Reality in Medicine,
and Cyberpsychology, Behavior, and Social Networking.
Board Positions: Walter serves on the Board of Directors for Brainstorm:
The Stanford Laboratory for Brain Health Innovation and Entrepreneurship;
for Cognitive Leap, a company that develops mental health solutions for
children; and for Sine Wave, the developer of Sine Space, a
multi-user online Unity 3D-based virtual world platform. He is currently the
technology and neuroscience advisor to several early-stage medical product
companies. Walter serves on the advisory board to several venture investment
firms and accelerator / incubator programs.
Walter earned a Doctorate in Neuro and
Bio-Behavioral Sciences from the Stanford University School of Medicine, where
he was awarded a NIMH Graduate Fellowship.
- Lecture Material:
- Pre-lecture slides - 1.42 Mb pdf file
- Slides - 10.8 Mb pdf file
- Virtual Human Interaction Lab
- International Virtual Reality Health
- National Mental Health Innovation